Signa S.A. de C.V.April 15, 2022

FDA 483 - Signa S.A. de C.V. - April 15, 2022

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Signa S.A. de C.V.

Record Details

Signa S.A. de C.V., an API manufacturer in Toluca De Lerdo, Mexico, was cited for significant deficiencies in its quality control unit and manufacturing processes. The inspection revealed inadequate controls over computerized systems, failures to follow written procedures for investigations and deviations, and incomplete cleaning validation studies. These issues indicate a lack of robust quality oversight and potential risks to data integrity and product quality.

Company: Signa S.A. de C.V.
Inspection Date: April 15, 2022
Product Type: Drugs
Office: Office of Biological Products Operations - Division I
People: Lisa Shin (Investigator)
Joel D. Hustedt

Open in Dashboard

ID · d31d440d-6633-4f78-9d9d-4856ac694ad0